REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE

Clinical trials for REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE trials appear

Sign up with your email to follow new studies for REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Supercharged immune cells: new hope for tough leukemia cases

Disease control Recruiting now

This early-phase study is testing the safety of a new type of CAR T-cell therapy for adults and teenagers (12+) with acute lymphoblastic leukemia (ALL) that has come back or not responded to other treatments. Doctors take a patient's own immune cells, modify them in a lab to bett…

Matched conditions: REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE

Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE

Get alerted when new REFRACTORY ACUTE LYMPHOID LEUKEMIA IN RELAPSE trials appear

Supercharged immune cells: new hope for tough leukemia cases